Your browser doesn't support javascript.
loading
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3).
Takahashi, Masanobu; Kato, Ken; Okada, Morihito; Chin, Keisho; Kadowaki, Shigenori; Hamamoto, Yasuo; Doki, Yuichiro; Kubota, Yutaro; Kawakami, Hisato; Ogata, Takashi; Hara, Hiroki; Muto, Manabu; Nakashima, Yuichiro; Ishihara, Ryu; Tsuda, Masahiro; Motoyama, Satoru; Kodani, Mamoru; Kitagawa, Yuko.
Afiliação
  • Takahashi M; Department of Medical Oncology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai-shi, Miyagi, 980-8574, Japan. masanobu.takahashi.a7@tohoku.ac.jp.
  • Kato K; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Okada M; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Chin K; Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Hamamoto Y; Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
  • Doki Y; Department of Surgery, Osaka University Hospital, Osaka, Japan.
  • Kubota Y; Department of Medicine, Division of Medical Oncology, Showa University School of Medicine, Tokyo, Japan.
  • Kawakami H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
  • Ogata T; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Hara H; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Muto M; Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan.
  • Nakashima Y; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Ishihara R; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Tsuda M; Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan.
  • Motoyama S; Department of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Kodani M; Department of Oncology, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
  • Kitagawa Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
Esophagus ; 18(1): 90-99, 2021 01.
Article em En | MEDLINE | ID: mdl-33170461

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Esophagus Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Esophagus Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão